Role of Th1 and Th2 cells in human allergic disorders

Chemical Immunology

Volumn 63, Issue , 1996, Pages 187-203

  Robinson, Douglas S ^a   Kay, A Barry ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CORTICOSTEROID; IMMUNOGLOBULIN E;

ALLERGY; ATOPY; CONTROLLED STUDY; EOSINOPHIL; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MAST CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

HUMANS; HYPERSENSITIVITY, IMMEDIATE; TH1 CELLS; TH2 CELLS;

EID: 0029878572     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (113)

1. Mosmann TR, Cherwinski H, Bond MW, Gieldin MA, Coffman RL: Two types of murine helper T cell clones. J Immunol 1986; 136:2348-2357.
2. Mosmann TR, Coffman RL: Two types of mouse helper T cell clone: Implications for immune regulation Immunol Today 1987,8:223-227.
3. Bottomly K: A functional dichotomy in CD4+ T lymphocytes. Immunol Today 1988;9:268-330.
4. Romagnani S: Human Th1 and Th2: Doubt no more. Immunol Today 1991;12:256-257.
5. Coca AF, Cooke RA: On the classification of the phenomena of hypersensitiveness J Immunol 1923;8.163-175.
6. Ishisaka K, Ishisaka T: Identification of of-antibodies as a carrier of reaginic activity. J Immunol 1967;99:1187-1198.
7. Geha RS: Regulation of IgE synthesis in humans. J Allergy Clin Immunol 1992;90:143-150.
8. Sutton BJ, Gould HJ: The human IgE network. Nature 1993;366:421 428.
9. Vercelli D, Jabara HH, Arai K, Geha RS: Induction of human IgE synthesis requires interleukin-4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens. J Exp Med 1989,169:1295-1308.
10. Gauchat JF, Lebman DA, Coffman RL, Gascan H, de Vries JE: Structure and expression of germline ε transcripts in human B cells induced by interleukin-4 to switch to IgE production. J Exp Med 1990;172:463-473.
11. Del Prete GF, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, Ricci M, Banchereau J, de Vries JE, Romagnani S: IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988;140:4193-4198.
12. Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE: Interleukin 13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993;90.3730-3734.
13. Zurawski G, de Vries JE: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells Immunol Today 1994,15:19-26.
14. 2 Proc Natl Acad Sci USA 1988;85:6880-6884.
15. Jabara HH, Fu SM, Geha RS, Vercelli D: CD40 and IgE: Synergism between anti-CD40 mAb and IL-4 in the induction of IgE synthesis by highly purified human B cells. J Exp Med 1990;172: 1861-1865.
16. Gauchat JF, Henchoz S, Mazzei G, Aubry JP, Brunner T, Blasey H, Life P, Talabot D, Flores Romo L, Thompson J, Butterfield J, Dahinden C, Bonnefoy JY: Induction of human IgE synthesis by mast cells and basophils. Nature 1993;65:340-343.
17. Pene J, Rousset F, Briere F, Chretien I, Widemann J, Bonnefoy JY, de Vries J Interleukin 5 enhances interleukin-4-induced IgE production by normal human B cells: The role of soluble CD23 antigen. Eur J Immunol 1988;18:929-935.
18. Vercelli D, Jabara HH, Arai K, Yokota T, Geha RS Endogenous IL-6 plays an obligatory role in IL-4-induced human IgE synthesis. Eur J Immunol 1989,19:1419-1424.
19. Kimata H, Yoshida A, Ishioka C, Lindley I, Mikawa H: Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells. J Exp Med 1992;176:1227-1231.
20. Kiniwa M, Gateley M, Chizzonite R, Fargeas C, Delespesse G: Recombinant interleukin 12 suppresses the synthesis of immunoglobulin E by intereleukin 4 stimulated human lymphocytes. J Clin Invest 1992;90:262-266.
21. Gauchat JF, Aversa G, Gascan H, de Vries JE: Modulation of IL-4 induced germline epsilon RNA synthesis in human B cells by tumour necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production. Int Immunol 1992;4: 397-406.
22. Gleich GJ: The eosinophil and bronchial asthma: Current understanding J Allergy Clin Immunol 1990;85:422-436.
23. Varney VA, Jacobson MR, Sudderick RM, Robinson DS, Irani A-M, Schwartz LB, Mackay IS, Kay AB, Durham SR: Immunohistology of the nasal mucosa following allergen-induced rhinitis. Am Rev Respir Dis 1992;146:170-176.
24. Bruijnzeel-Koomen CAFM, Wichen DF, Spry CJF, Venge P, Bruijnzeel PLB Active participation of eosinophil in patch test reactions to inhalent allergens in patients with atopic dermatitis. Br J Dermatol 1988;118:229-238.
25. Shaw RJ, Walsh GM, Crornwell O, Moqbel R, Spry CJF, Kay AB: Activated human eosinophils generate SRS-A leukotrienes following physiological (IgG dependent) stimulation. Nature 1985; 316:150-152.
26. Frigas E, Loegering DA, Solley G, Farrow G, Gleich GJ: Elevated levels of the eosinophil major basic protein in the sputum of patients with bronchial asthma Mayo Clin Proc 1981;56:345-353.
27. Gleich GJ, Adolphson CR, Leiferman KL: The biology of the eosinophil leukocyte. Annu rev Med 1993;44:85-101.
28. Dunnill MS: The pathology of asthma with special reference to changes in the bronchial mucosa. J Clin Pathol 1968;13 27-33
29. Robinson DS, Bentley AM, Hartnell AH, Kay AB, Durham SR: Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: Relation to asthma symptoms, lung function and bronchial hyperresponsiveness. Thorax 1992;48:26-32.
30. Wilson JW, Djukanovic R, Howarth PH, Holgate ST: Lymphocyte activation in bronchoalveolar lavage and peripheral blood in atopic asthma. Am Rev Respir Dis 1992;145:958-960.
31. Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles GK, Assoufi B, Collins JV, Durham SR, Kay AB: Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990,142:1407-1413.
32. Zachary CB, Allen MH, MacDonald DM In situ quantification of T lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema. Br J Dermatol 1985;112: 149-156.
33. Corrigan CJ, Kay AB: T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992; 13.501-507.
34. Clutterbuck EJ, Hirst EMA, Sanderson CJ: Human interleukin 5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 1989;73:1504-1513.
35. Yamaguchi Y, Hayashi Y, Suguma Y, Miura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K, Suda T: Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. J Exp Med 1988,167.1737-1742.
36. Her E, Frazer J, Austen KF, Owen WF Jr: Eosinophil haematopoietins antagonize the programmed cell death of eosinophils. J clin Invest 1991,88:1982-1987.
37. Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 1992; 148.3543-3549.
38. Walsh GM, Hartnell AH, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB: IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/18)-dependent manner. Immunology 1990;71.258-265.
39. Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB: Interleukin 5 (IL-5) selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 1992;79:2952-2959
40. Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990; 144:642-646.
41. Rothenberg ME, Owen WF, Silberstein DS, Woods J, Soberman RJ, Austen KF, Stevens RL: Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukm-3 J Clin Invest 1989,81:1986-1992.
42. Lopez AF, Williamson DJ, Gamble JR, Begley CG, Harian JM, Klebanoff SJ, Walterdorph A, Wong G, Clark SC, Vadas MA: Recombinant human granulocyte macrophage colony-stimulating factor stimulates in vitro mature human eosinophil and neutrophil function, surface receptor expression and survival J Clin Invest 1986;78 1220-1228.
43. Walsh GM, Hartnell AH, Mermod J-J, Kay AB, Wardlaw AJ: Human eosinophil, but not neutrophil, adherence to IL-1 stimulated HUVEC is α4/β1 (VLA4) dependent. J Immunol 1991;146:3419-3423.
44. Pahard X, de Waal Malefyt R, Yssel H, Blanchard D, Chretien I, Abrams J, de Vries J, Spits H: Simultaneous production of IL-2, IL-4 and and IFNτ by activated human CD4+ and CD8+ T cell clones J Immunol 1988;141:849-855.
45. Umetsu D, Jabara HH, DeKruyff RH, Abbas AK, Abrams JS, Geha RS. Functional heterogeneity among human inducer T cell clones. J Immunol 1988,140:4211-4216.
46. Quint DJ, Bolton EJ, McNamee LA, Solari R, Hissey PH, Champion BR, Mackenzie AR, Zanders ED: Functional and phenotypic analysis of human T cell clones which stimulate IgE production in vitro Immunology 1989;67.68-74.
47. O'Hehir RE, Bal V, Quint DJ, Moqbel R, Kay AB, Zanders ED, Lamb JR: An in vitro model of allergen-dependent IgE synthesis by human B lymphocytes: Comparison of the response of an atopic and a non atopic individual to Dermatophagoides spp. (house dust mite). Immunology 1989; 66:499-504.
48. Wierenga EA, Snoek M, de Groot C, Chretien I, de Bos J, Jansen HM, Kapsenberg ML: Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990;144:4651-4656.
49. Parronchi P, Macchia D, Piccint M-P, Biswas P, Simonelli C, Maggi E, Ricci M, Ansari AA, Romagnant S: Allergen- and bacterial antigen-specific T cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 1991;88:4538-4542.
50. Yssel H, de Waal Malefyt R, Roncarolo M-G, Abrams J, Lahesmaa R, Spits H, de Vries JE: IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 1992;149:2378-2384.
51. Del Prete G, de Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S: Human IL-10 is produced both by type 1 helper (ThI) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993;150:353-360.
52. Walker C, Virchow J-C, Bruijnzeel PLB, Blaser K: T cell subsets and their soluble products regulate eosinophilia in allergic and non-allergic asthma. J Immunol 1991;146:1829-1835.
53. Corrigan CJ, Haczku A, Gemou-Engesaeth V, Doi S, Kikuchi Y, Takatsu K, Durham SR, Kay AB: CD4 T lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Am Rev Respir Dis 1993;147:540-547.
54. Cogan E, Schandene L, Cruisiaux A, Cochaux P, Velu T, Goldman M: Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994;330: 535-538.
55. Romagnani S: Regulation of the development of type 2 T helper cells in allergy Curr Opin Immunol 1994;6:838-846.
56. Wierenga EA, Snoek M, Jansen HM, Bos JD, van Lier RAW, Kapsenberg ML: Human atopenspecific types 1 and 2 T helper cell clones. J Immunol 1991;147:2942-2949.
57. Maggi E, Biswas P, Del Prete G, Parronchi P, Macchia D, Simonelli C, Emmi L, de Carh M, Tiri A, Ricci M, Romagnani S: Accumulation of Th2-like helper T cells in the conjunctiva of patients with vernal conjunctivitis J Immunol 1991;146:1169-1174.
58. Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C: House dust mite-specific T cells in the skin of subjects with atopic dermatitis: Frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol 1992;89:801-810.
59. van Reijsen FC, Bruijnzeel-Koomen CAFM, Kalthoff FS, Maggi E, Romagnani S, Westland JKT, Mudde GC. Skin-derived aeroallergen-specific T cell clones of Th2 phenotype in patients with atopic dermatitis. J Allergy clin Immunol 1992;90:184-192.
60. Del Prete G, de Carli M, d'Elios MM, Maestrelli P, Ricci M, Fabbri L, Romagnani S: Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993;23:1445-1449
61. Bentley AM, Maestrelli P, Saetta M, Fabbri L, Robinson DS, Bradley BL, Jeffery PK, Durham SR, Kay AB: Activated T lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. J Allergy Clin Immunol 1992,89:821-829.
62. Robinson DS, Hamid Q, Sun Ying, Tsicopoulos A, Barkans J, Bentley AM, Corrigan CJ, Durham SR, Kay AB: Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
63. Robinson DS, Sun Ying, Bentley AM, Qiu Meng, North J, Durham SR, Kay AB, Hamid Q: Relationships among numbers of bronchoalveolar lavage cells expressing mRNA for cytokines asthma symptoms, and airway methacholine responsiveness in atopic asthma J Allergy Clin Immunol 1993;92:397-403.
64. Sun Ying, Durham SR, Corrigan CJ, Hamid Q, Kay AB: Phenotype of cells expressing mRNA for Th2-type (interleukin 4 and interleukin 5) and Th1-type (interleukin 2 and interferon-τ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol. in press.
65. Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients: Relationship to atopic status, symptoms and level of airway responsiveness. Chest 1994;105:687-696.
66. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow J-C Jr: Allergic and nonallergic asthmatics have distinct patterns of T cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992,146:109-115.
67. Bentley AM, Menz G, Storz CHR, Robinson DS, Bradley B, Jeffery PK, Durham SR, Kay AB: Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Am Rev Respir Dis 1992;146:500-506.
68. Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, Menz G, Barkans J, Sun Ying, Kay AB: High affinity immunoglobulin E receptor (FcεR1)-bearing cells in bronchial biopsies from atopic and non-atopic ('intrinsic') asthma, submitted.
69. Kay AB, Sun Ying, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q: Messenger RNA expression of the cytokine gene cluster interleukin-3 (IL-3), IL-4, IL-5 and granulocyte/ macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-778.
70. Durham SR, Sun Ying, Varney VA, Jacobson MR, Suddenck RM, Mackay IS, Kay AB, Hamid QA: Cytokine messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage colony-stimuiating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia. J Immunol 1992;148:2390-2394.
71. Bentley AM, Meng Q, Robinson DS, Hamid Q, Kay AB, Durham SR. Increases in activated T lymphocytes, eosinophils. and cytokine mRNA expression for interleukin-5 and granulocyte/ macrophage colony-stimulating factor in bronchial biopsies after allergen challenge in atopic asthmatics. Am J Respir Cell Mol Biol 1993;8:35-42
72. Robinson DS, Hamid Q, Bentley AM, Sun Ying, Kay AB, Durham SR: Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92: 313-324.
73. Sun Ying, Durham SR, Barkans J, Masuyarna K, Jacobson M, Rak S, Lowhagen O, Moqbel R, Kay AB, Hamid Q: T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am J respir Cell Mol Biol 1993;9.356-360.
74. Sedgwick JB, Calhoun WJ, Gleich GJ, Kita H, Abrams JS, Schwartz LB, Volovitz B, Ben-Yaakov M, Busse WW: Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Am Rev Respir Dis 1991;144:1274-1281.
75. Broide DH, Firestein GS: Endobronchial allergen challenge in asthma: demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization. J Clin Invest 1991,88:1048-1053
76. Broide DH, Paine MM, Firestein GS Eosinophils express interleukin-5 and granulocyte macrophage colony stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 1992; 90:1414-1424.
77. Gillis S, Crabtree GR, Smith KA Glucocorticoid-induced inhibition of T cell growth factor production I The effect on mitogen-induced lymphocyte proliferation J Immunol 1979;123:1624-1631.
78. Byron KA, Varigos G, Wooton A: Hydrocortisone inhibition of human interleukin 4. Immunology 1992;77:624-626.
79. Rolfe FG, Hughes JM, Armour CL, Sewell WA: Inhibition of interleukin 5 gene expression by dexamethasone. Immunology 1992;77.494-499.
80. Arya SK, Wong-Staal F, Gallo RC: Dexamethasone-mediated inhibition of human T cell growth factor and interferon-γ messenger RNA. J Immunol 1984,133:273-276.
81. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, Holgate ST: Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma Am Rev Respir Dis 1992;145:669-674
82. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, Johansson S-A: Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 1992;145:890-899
83. Robinson DS, Hamid Q, Sun Ying, Bentley AM, Assoufi B, Durham SR, Kay AB: Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage interleukin-4, interleukin-5 and interferon-γ cytokine gene expression. Am Rev Respir Dis 1993;148:401-406.
84. Leung DYM, Martin RJ, Szefler SJ, Sher ER, Sun Ying, Qiu Meng, Kay AB, Hamid Q: The airways of steroid resistant versus steroid sensitive asthma are associated with different patterns of cytokine gene expression. J Exp Med 1995;181.33-40.
85. Hamid Q, Sun Ying, Robinson DS, Durham SR, Kay AB IL-10 mRNA is increased in asthma and co-localised with CD3 and CD68. Am J Respir Crit Care Med 1994;149.A958.
86. Noon L: Prophylactic inoculation against hay fever. Lancet 1911;i:1572-1573.
87. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR: Usefulness of immunotherapy in patients with severe hayfever uncontrolled by antiallergic drugs. Br Med J 1991;302:265-269.
88. Bousquet J, Becker WM, Heijaoui A, Chanal CP, Lebel B, Dhivert H, Michel FB: Clinical and immunological reactivity of patients allergic to grass pollens and multiple pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol 1991;89:43.
89. O'Hehtr RE, Busch R, Rothbard JB, Lamb JR: An in vitro model of peptide-mediated immunomodulation of the human T cell response to Dermatophagoides spp. (house dust mite). J Allergy Clin Immunol 1991;87:1120-1127.
90. Hoyne GJ, O'Hehir RE, Wraith DC, Thomas WR, Lamb JR: Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice J Exp Med 1993;178:1783-1788.
91. Secrist H, Chelen CJ, Yan Wen, Marshall JD, Umetsu DT: Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:2123-2130.
92. Varney VA, Hamid Q, Gaga M, Sun Ying, Jacobson M, Frew AJ, Kay AB, Durham SR: Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92:644-651.
93. Durham SR, Schotman E, Jacobson M, Walker S, Hamid Q: Grass pollen immunotherapy (IT): Inhibition of allergen-induced late skin responses (LPR) is associated with an increase in IL-12 messenger RNA+ cells. J Allergy Clin Immunol 1995;95:304.
94. Manetti R, Parronchi P, Guidizi MG, Piccini M-P, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory factor interleukin 12 (IL-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4 producing Th cells. J Exp Med 1993;177:1199.
95. Marsh DG, Meyers DA: A major gene for allergy: Fact or fancy. Nature Genet 1992;2:252-254.
96. Sandford AJ, Shirikawa T, Moffat MF, Daniels SE, Ra C, Faux JA, Young RP, Nakamura Y, Lathrop GM, Cookson WOCM, Hopkin JM Localisation of atopy and β subunit of high affinity IgE receptor (FcεR1) on chromosome 11q. Lancet 1993;341:332-334.
97. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrhch-Kautzky E, Schou C, Krishaswamy G, Beaty TH: Linkage analysis of IL-4 and other chromosome 5q31.1 markers and total serum IgE. Science 1994,264:1152-1156.
98. Warner JA, Miles EA, Jones AC, Quint DJ, Colwell BM, Warner JO: Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic asthma? Clin Exp Allergy 1994;24:423-430.
99. Arshad SH, Matthews S, Gant C, Hide DW: Effect of allergen avoidance on development of allergic disorders in infancy. Lancet 1993;339:1493-1497.
100. Sporik R, Holgate ST, Platts-Mills TAE, Cogswell JJ: Exposure to house dust mite allergen (Der p 1) and the development of asthma in childhood. N Engl J Med 1990;323:502-507.
101. Holt PG: A potential vaccine strategy for asthma and allied atopic diseases during early childhood. Lancet 1994;344:456-458
102. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, Shevach EM, Rocken M: Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 1994;180:1961-1966.
103. Maggi E, Parronchi P, Manetti R, Simonelli C, Piccini M-P, Rugiu FS, de Carli M, Ricci M, Romagnani S: Reciprocal effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones J Immunol 1992;148:2142-2147.
104. Hsieh C-S, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 1993;260: 547-549.
105. Kopf M, le Gros G, Bachmann M, Larners MC, Bluthmann H, Kohler G: Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 1993;362:245-248.
106. Bradding P, Feather IH, Howarth PH, Mueller R, Roberts JA, Britten K, Bews JPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST: Interleukin 4 is localised to and released by human mast cells. J Exp Med 1992;176:1381-1386.
107. Brunner T, Heusser CH, Dahinden CA: Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 1993;177: 605-611.
108. Moqbel R, Sun Ying, Barkans J, Wakelin M, Kimmit P, Corrigan CJ, Durham SR, Kay AB: Eosinophils transcribe and translate mRNA for IL-4 (abstract). J Allergy Clin Immunol 1995;95: 221
109. Soussi Gouni A, Lamkhloued B, Ochiai K, Tanaka Y, Delaporte E, Capron A, Kinet J-P, Capron M High affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994; 367:183-186.
110. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3 J Exp Med 1994;179:1285-1295.
111. Daynes RA, Araneo BA, Dowell TA, Huang K, Dudley D: Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med 1990;171:979-996.
112. Rook GAW, Hernandez-Pando R, Lightman SL: Hormones, peripherally activated prohormones, and regulation of the Th1/Th2 balance. Immunol Today 1994;15 301-303.
113. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995;80:707-718.